Frauke Noessler
About Frauke Noessler
Frauke Noessler is a Medical Content and Communication Specialist in Immunooncology Pan Tumor at Bristol Myers Squibb in Munich, Germany, with extensive experience in oncology and cardiovascular fields.
Current Role at Bristol-Myers Squibb
Frauke Noessler is currently serving as a Medical Content and Communication Specialist in Immuno-oncology Pan Tumor at Bristol-Myers Squibb, based in Munich, Bayern, Deutschland. In this role, she is responsible for co-leading the worldwide pan-tumor and safety content team. She focuses on creating scientific content and training field medical colleagues and physicians on various immuno-oncology topics, including adverse event management under checkpoint inhibitors and resistance mechanisms.
Experience as Melanomspezialistin
From 2011 to 2015, Frauke Noessler was a Melanomspezialistin at Bristol-Myers Squibb in Ingolstadt. During these four years, she significantly contributed to the understanding and management of melanoma, playing a key role in supporting various melanoma-focused initiatives and educational programs aimed at both healthcare professionals and patients.
Background in Oncology and Cardiovascular Sales
Frauke Noessler has an extensive background with Bristol-Myers Squibb, having served in various roles including Salesforce Specialist Oncology for five years (2006-2011) and Außendienstmitarbeiter Cardiovascular for three years (2002-2005) in Ingolstadt. These positions enabled her to develop significant expertise in both oncology and cardiovascular sales, enhancing her ability to manage complex medical communications and sales strategies.
Educational Background and Early Career
Frauke Noessler earned her Dr. rer. nat in Verhaltenswissenschaften from Humboldt-Universität zu Berlin, where she studied from 1987 to 1992. Her early career included a six-year tenure as Büroleiter at Planungsbüro Dr. Nößler in Berlin und Umgebung, Deutschland. This foundational experience provided her with significant administrative and leadership skills that would later benefit her roles in the pharmaceutical industry.
Expertise in Tumor Biology and Immunology
Frauke Noessler has a comprehensive understanding of tumor biology, tumor immunology, and clinical data related to checkpoint inhibitors. Since 2017, she has been focusing on various cancer types such as melanoma, bladder cancer, and renal cell carcinoma (RCC), as well as early assets and biomarkers. Her expertise also extends to creating and managing scientific content like slide decks and Q&A materials on both global and local levels.